Inhaltsbereich
| 235 Einträge | 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12 › » |
Seite 1 / 12
 Druckansicht
|
| Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial. |
| Martin M, Holmes FA, Ejlertsen B, Delaloge S, Moy B, Iwata H, von Minckwitz G, Chia SKL, Mansi J, Barrios CH, Gnant M, Tomašević Z, Denduluri N, Šeparović R, Gokmen E, Bashford A, Ruiz Borrego M, Kim SB, Jakobsen EH, Ciceniene A, Inoue K, Overkamp F, Heijns JB, Armstrong AC, Link JS, Joy AA, Bryce R, Wong A, Moran S, Yao B, Xu F, Auerbach A, Buyse M, Chan A |
| The Lancet. Oncology. 2017 Nov 13. pii: S1470-2045(17)30717-9. doi: 10.1016/S1470-2045(17)30717-9 |
| PMID: 29146401 |
| Overall survival with neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): A randomised, double-blind, placebo-controlled, phase 3 trial. |
| Holmes FA, Moy B, Delaloge S, Chia SKL, Ejlertsen B, Mansi J, Iwata H, Gnant M, Buyse M, Barrios CH, Silovski T, Šeparović R, Bashford A, Zotano AG, Denduluri N, Patt D, Gokmen E, Gore I, Smith JW, Loibl S, Masuda N, Tomašević Z, Petráková K, DiPrimeo D, Wong A, Martin M, Chan A |
| European journal of cancer (Oxford, England : 1990). 2023 Feb 10. doi: 10.1016/j.ejca.2023.02.002. pii: S0959-8049(23)00063-1 |
| PMID: 36898233 |
| Collaborative Efforts Driving Progress in Pediatric Acute Myeloid Leukemia. |
| Zwaan CM, Kolb EA, Reinhardt D, Abrahamsson J, Adachi S, Aplenc R, De Bont ES, De Moerloose B, Dworzak M, Gibson BE, Hasle H, Leverger G, Locatelli F, Ragu C, Ribeiro RC, Rizzari C, Rubnitz JE, Smith OP, Sung L, Tomizawa D, van den Heuvel-Eibrink MM, Creutzig U, Kaspers GJ |
| Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2015 Aug 24. pii: JCO.2015.62.8289. doi: 10.1200/JCO.2015.62.8289 |
| PMID: 26304895 |
| Stem cell transplantation in severe congenital neutropenia: an analysis from the European Society for Blood and Marrow Transplantation. |
| Fioredda F, Iacobelli S, van Biezen A, Gaspar B, Ancliff P, Donadieu J, Aljurf M, Peters C, Calvillo M, Matthes-Martin S, Morreale G, van 't Veer-Tazelaar N, de Wreede L, Al Seraihy A, Yesilipek A, Fisher A, Bierings M, Ozturk G, Smith O, Veys P, Ljungman P, Peffault Delatour R, de Toledo Codina JS, Or R, Ganser A, Afanasyev B, Wynn R, Kalwak K, Marsh J, Dufour C |
| Blood. 2015 Jul 16. pii: blood-2015-02-628859. doi: 10.1182/blood-2015-02-628859 |
| PMID: 26185129 |
| Pharmacological targeting of the Wdr5-MLL interaction in C/EBPα N-terminal leukemia. |
| Grebien F, Vedadi M, Getlik M, Giambruno R, Grover A, Avellino R, Skucha A, Vittori S, Kuznetsova E, Smil D, Barsyte-Lovejoy D, Li F, Poda G, Schapira M, Wu H, Dong A, Senisterra G, Stukalov A, Huber KV, Schönegger A, Marcellus R, Bilban M, Bock C, Brown PJ, Zuber J, Bennett KL, Al-Awar R, Delwel R, Nerlov C, Arrowsmith CH, Superti-Furga G |
| Nature chemical biology. 2015 Jul 13. pii: nchembio.1859. doi: 10.1038/nchembio.1859. pmc: PMC4511833. mid: EMS63643 |
| PMID: 26167872 |
| Management of patients with advanced prostate cancer: recommendations of the St Gallen Advanced Prostate Cancer Consensus Conference (APCCC) 2015. |
| Gillessen S, Omlin A, Attard G, de Bono JS, Efstathiou E, Fizazi K, Halabi S, Nelson PS, Sartor O, Smith MR, Soule HR, Akaza H, Beer TM, Beltran H, Chinnaiyan AM, Daugaard G, Davis ID, De Santis M, Drake CG, Eeles RA, Fanti S, Gleave ME, Heidenreich A, Hussain M, James ND, Lecouvet FE, Logothetis CJ, Mastris K, Nilsson S, Oh WK, Olmos D, Padhani AR, Parker C, Rubin MA, Schalken JA, Scher HI, Sella A, Shore ND, Small EJ, Sternberg CN, Suzuki H, Sweeney CJ, Tannock IF, Tombal B |
| Annals of oncology : official journal of the European Society for Medical Oncology / ESMO. 2015 Jun 3. pii: mdv257. doi: 10.1093/annonc/mdv257. pmc: PMC4511225 |
| PMID: 26041764 |
| Tailoring therapies-improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015. |
| Coates AS, Winer EP, Goldhirsch A, Gelber RD, Gnant M, Piccart-Gebhart M, Thürlimann B, Senn HJ |
| Annals of oncology : official journal of the European Society for Medical Oncology / ESMO. 2015 May 4. pii: mdv221. doi: 10.1093/annonc/mdv221. pmc: PMC4511219 |
| PMID: 25939896 |
| National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: V. The 2014 Ancillary Therapy and Supportive Care Working Group Report. |
| Carpenter PA, Kitko CL, Elad S, Flowers ME, Gea-Banacloche JC, Halter JP, Hoodin F, Johnston L, Lawitschka A, McDonald GB, Opipari AW, Savani BN, Schultz KR, Smith SR, Syrjala KL, Treister N, Vogelsang GB, Williams KM, Pavletic SZ, Martin PJ, Lee SJ, Couriel DR |
| Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 2015 Mar 31. pii: S1083-8791(15)00224-4. doi: 10.1016/j.bbmt.2015.03.024 |
| PMID: 25838185 |
| Outcomes and resource use of non-small cell lung cancer (NSCLC) patients treated with first-line platinum-based chemotherapy across Europe: FRAME prospective observational study. |
| Moro-Sibilot D, Smit E, de Castro Carpeño J, Lesniewski-Kmak K, Aerts J, Villatoro R, Kraaij K, Nacerddine K, Dyachkova Y, Smith KT, Taipale K, Girvan AC, Visseren-Grul C, Schnabel PA |
| Lung cancer (Amsterdam, Netherlands). 2015 Feb 21. pii: S0169-5002(15)00118-X. doi: 10.1016/j.lungcan.2015.02.011 |
| PMID: 25748103 |
| Criteria for evaluating response and outcome in clinical trials for children with juvenile myelomonocytic leukemia. |
| Niemeyer CM, Loh ML, Cseh A, Cooper T, Dvorak CC, Chan R, Xicoy B, Germing U, Kojima S, Manabe A, Dworzak M, De Moerloose B, Starý J, Smith OP, Masetti R, Catala A, Bergstraesser E, Ussowicz M, Fabri O, Baruchel A, Cavé H, Zwaan M, Locatelli F, Hasle H, van den Heuvel-Eibrink MM, Flotho C, Yoshimi A |
| Haematologica. 2015 Jan 1. pii: haematol.2014.109892. doi: 10.3324/haematol.2014.109892. pmc: PMC4281308 |
| PMID: 25552679 |
| Considerations when investigating lncRNA function in vivo. |
| Bassett AR, Akhtar A, Barlow DP, Bird AP, Brockdorff N, Duboule D, Ephrussi A, Ferguson-Smith AC, Gingeras TR, Haerty W, Higgs DR, Miska EA, Ponting CP |
| eLife. 2014 Aug 14. pmc: PMC4132285 |
| PMID: 25124674 |
| The prognostic significance of early treatment response in pediatric relapsed acute myeloid leukemia: results of the international study Relapsed AML 2001/01. |
| Creutzig U, Zimmermann M, Dworzak MN, Gibson B, Tamminga R, Abrahamsson J, Ha SY, Hasle H, Maschan A, Bertrand Y, Leverger G, von Neuhoff C, Razzouk B, Rizzari C, Smisek P, Smith OP, Stark B, Reinhardt D, Kaspers GL |
| Haematologica. 2014 Apr 24. pii: haematol.2014.104182. doi: 10.3324/haematol.2014.104182 |
| PMID: 24763401 |
| Cisplatin and carboplatin-based chemotherapy in the first-line treatment of non-small cell lung cancer: Analysis from the European FRAME study. |
| Smit E, Moro-Sibilot D, Carpeño Jde C, Lesniewski-Kmak K, Aerts J, Villatoro R, Kraaij K, Nacerddine K, Dyachkova Y, Smith KT, Girvan A, Visseren-Grul C, Schnabel PA |
| Lung cancer (Amsterdam, Netherlands). 2015 Dec 3. pii: S0169-5002(15)30118-5. doi: 10.1016/j.lungcan.2015.11.022 |
| PMID: 26775594 |
| Adjuvant bisphosphonates in early breast cancer: Consensus guidance for clinical practice from a European Panel. |
| Hadji P, Coleman RE, Wilson C, Powles TJ, Clézardin P, Aapro M, Costa L, Body JJ, Markopoulos C, Santini D, Diel I, Di Leo A, Cameron D, Dodwell D, Smith I, Gnant M, Gray R, Harbeck N, Thurlimann B, Untch M, Cortes J, Martin M, Albert US, Conte PF, Ejlertsen B, Bergh J, Kaufmann M, Holen I |
| Annals of oncology : official journal of the European Society for Medical Oncology / ESMO. 2015 Dec 17. pii: mdv617. doi: 10.1093/annonc/mdv617 |
| PMID: 26681681 |
| Non-small cell lung cancer patients with brain metastases treated with first-line platinum-doublet chemotherapy: Analysis from the European FRAME study. |
| Moro-Sibilot D, Smit E, de Castro Carpeño J, Lesniewski-Kmak K, Aerts JG, Villatoro R, Kraaij K, Nacerddine K, Dyachkova Y, Smith KT, Girvan A, Visseren-Grul C, Schnabel PA |
| Lung cancer (Amsterdam, Netherlands). 2015 Nov 10. pii: S0169-5002(15)30107-0. doi: 10.1016/j.lungcan.2015.11.011 |
| PMID: 26791802 |
| Neratinib after trastuzumab-based adjuvant therapy in patients with HER2-positive breast cancer (ExteNET): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. |
| Chan A, Delaloge S, Holmes FA, Moy B, Iwata H, Harvey VJ, Robert NJ, Silovski T, Gokmen E, von Minckwitz G, Ejlertsen B, Chia SK, Mansi J, Barrios CH, Gnant M, Buyse M, Gore I, Smith J, Harker G, Masuda N, Petrakova K, Zotano AG, Iannotti N, Rodriguez G, Tassone P, Wong A, Bryce R, Ye Y, Yao B, Martin M |
| The Lancet. Oncology. 2016 Feb 10. pii: S1470-2045(15)00551-3. doi: 10.1016/S1470-2045(15)00551-3 |
| PMID: 26874901 |
| Highlights of Children with Cancer UK's Workshop on Drug Delivery in Paediatric Brain Tumours. |
| Nailor A, Walker DA, Jacques TS, Warren KE, Brem H, Kearns PR, Greenwood J, Penny JI, Pilkington GJ, Carcaboso AM, Fleischhack G, Macarthur D, Slavc I, Meijer L, Gill S, Lowis S, van Vuurden DG, Pearl MS, Clifford SC, Morrissy S, Ivanov DP, Beccaria K, Gilbertson RJ, Straathof K, Green JJ, Smith S, Rahman R, Kilday JP |
| Ecancermedicalscience. 2016 Mar 31. doi: 10.3332/ecancer.2016.630. pii: can-10-630 |
| PMID: 27110286 |
| The potential yield of Tai Chi in cancer survivorship. |
| Smith L, Gordon D, Scruton A, Yang L |
| Future science OA. 2016 Oct 20. doi: 10.4155/fsoa-2016-0049 |
| PMID: 28116134 |
| Characterization of leukemias with ETV6-ABL1 fusion. |
| Zaliova M, Moorman AV, Cazzaniga G, Stanulla M, Harvey RC, Roberts KG, Heatley SL, Loh ML, Konopleva M, Chen IM, Zimmermannova O, Schwab C, Smith O, Mozziconacci MJ, Chabannon C, Kim M, Falkenburg JH, Norton A, Marshall K, Haas OA, Starkova J, Stuchly J, Hunger SP, White D, Mullighan CG, Willman CL, Stary J, Trka J, Zuna J |
| Haematologica. 2016 May 26. pii: haematol.2016.144345. doi: 10.3324/haematol.2016.144345 |
| PMID: 27229714 |
| Phase III Study of Cabozantinib in Previously Treated Metastatic Castration-Resistant Prostate Cancer: COMET-1. |
| Smith M, De Bono J, Sternberg C, Le Moulec S, Oudard S, De Giorgi U, Krainer M, Bergman A, Hoelzer W, De Wit R, Bögemann M, Saad F, Cruciani G, Vuillemin AT, Feyerabend S, Miller K, Houédé N, Hussain S, Lam E, Polikoff J, Stenzl A, Mainwaring P, Ramies D, Hessel C, Weitzman A, Fizazi K |
| Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2016 Jul 11. pii: JCO.2015.65.5597. doi: 10.1200/JCO.2015.65.5597 |
| PMID: 27400947 |
| 235 Einträge | 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12 › » |
Seite 1 / 12
Druckansicht
|
Schnellinfo
-- Initiative Krebsforschung / Krebsforschungslauf
-- Cancer Care
-- Kliniken und Partner
-- CCC Cancer School
-- Young CCC
-- CCC Tumorboards
-- CCC Forschungscluster
-- CCC Units
-- CCC Platforms
-- SOPs / Leitlinien
-- Kontakt
-- Cancer Care
-- Kliniken und Partner
-- CCC Cancer School
-- Young CCC
-- CCC Tumorboards
-- CCC Forschungscluster
-- CCC Units
-- CCC Platforms
-- SOPs / Leitlinien
-- Kontakt
Featured
